Status:
UNKNOWN
Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
Brief Summary
It is a real-world observational cross-sectional follow-up study on clinical palliative care for pancreatic cancer patients in China. It is evaluated by an online questionnaire sent to the doctors fro...
Detailed Description
Pancreatic cancer is a highly malignant gastrointestinal tumor with only a 10% overall 5-year survival rate. More than 80% of patients are already in the advanced stage when diagnosed, losing the chan...
Eligibility Criteria
Inclusion
- Doctors from the General Surgery Department in Chinese public tertiary teaching hospitals and public primary care units
- Approval to participate
- Participants with a valid and complete questionnaire evaluated by 2 experienced surgeons
Exclusion
- Refusal to participate
- Participants with an invalid or incomplete questionnaire
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06090825
Start Date
September 1 2023
End Date
September 1 2025
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730